1. Home
  2. CTGO vs ARVN Comparison

CTGO vs ARVN Comparison

Compare CTGO & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Contango ORE Inc.

CTGO

Contango ORE Inc.

HOLD

Current Price

$17.22

Market Cap

481.3M

ML Signal

HOLD

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$8.35

Market Cap

516.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTGO
ARVN
Founded
2009
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
481.3M
516.2M
IPO Year
2010
2018

Fundamental Metrics

Financial Performance
Metric
CTGO
ARVN
Price
$17.22
$8.35
Analyst Decision
Strong Buy
Buy
Analyst Count
1
19
Target Price
$41.00
$15.05
AVG Volume (30 Days)
775.0K
760.4K
Earning Date
05-13-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
19.77
58.84
EPS
N/A
N/A
Revenue
N/A
$262,600,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.50
$6.06
52 Week High
$34.38
$14.22

Technical Indicators

Market Signals
Indicator
CTGO
ARVN
Relative Strength Index (RSI) 48.95 53.38
Support Level $16.37 N/A
Resistance Level $18.50 $10.18
Average True Range (ATR) 0.91 0.42
MACD 0.36 0.16
Stochastic Oscillator 67.50 77.70

Price Performance

Historical Comparison
CTGO
ARVN

About CTGO Contango ORE Inc.

Contango Silver & Gold Inc, formerly Contango Ore Inc operates in the United States. The company is engaged in the exploration for and development of gold ore and associated minerals in the State of Alaska. The company's focus is the exploration of a mineral lease with the Native Village of Tetlin, whose governmental entity is the Tetlin Tribal Council, for the exploration of minerals near Tok, Alaska. It has formed a joint venture to advance exploration of the Tetlin Property, which is prospective for gold and associated minerals. The Peak Gold JV Property is located in the Tetlin Hills and Mentasta Mountains of eastern interior Alaska. Its exploration projects are Lucky Shot, Johnson Tract, Eagle, Hona, Shamrock, and Triple Z.

About ARVN Arvinas Inc.

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

Share on Social Networks: